With the availability of a new class of antivirals targeting the viral protein neuraminidase, there are new options for the control of influenza. The use of the older antiviral agents (M2 ...

Two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), and the M2 ion-channel protein are embedded in the viral envelope, which is derived from the host's plasma membrane.

Highly pathogenic avian influenza H5N9 has been identified in U.S. poultry for the first time, after outbreak at a commercial ...

Influenza is a viral respiratory disease that affects millions annually, with severe complications that can be fatal. Antiviral medications such as neuraminidase inhibitors, like oseltamivir ...

The flu is a disease of the respiratory system involving the mouth, nose, throat and occasionally the bronchi and lungs.

Limitations in current antiviral treatments, including resistance to neuraminidase inhibitors ... Secondary endpoints included viral load reduction, time to viral clearance, and safety assessments.